Global Customs & Trade Compliance Analyst at Bristol-Myers Squibb

Hyderabad, Telangana, India

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Knowledge of International Trade Laws and Regulations
Strong interpersonal skills, team player, willing to work in an environment requiring individual initiative and accountability
Ability to work independently with limited day-to-day supervision
Detail- and compliance-oriented with technical writing skills
Strong technical skills
Self-starter, proactive, flexible to interact with all teams, areas, and levels of business
Strong communication and presentation skills
2-5 years of experience in a pharmaceutical environment and expertise on International Trade regulations and requirements for import/export shipments of specialty pharmaceuticals

Responsibilities

Determination, management, automation advancement for the intake of assignment and recordkeeping of commodity codes for various markets
Support various markets on process implementation for valuation adjustments/reconciliation programs
Facilitate the maintenance of files, data, and other supporting information for imports and exports for an audit-ready state
Coordinate with internal customers in response to audits or other requests for information pertaining to company import/export activities
Support Customs & Trade as needed with Analytics - analytical data gathering and management support for the Customs Classification database, volume/value/audit metrics, drawback, special projects, and other needs as determined
Perform other duties that may be assigned or required to support Global Customs and Trade Compliance

Skills

Customs Compliance

Trade Compliance

Commodity Codes

Valuation Adjustments

Reconciliation

Import Export

Audit Support

Data Analytics

Automation

Classification Database

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free